John Sperzel

Track

Insider profile

Currently holds a position at Chembio Diagnostics Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -50% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Chembio Diagnostics Inc Oct. 1, 2017 -
President, Chief Executive Officer, Director Chembio Diagnostics Inc Oct. 1, 2017 - Jan. 9, 2020
President, Chief Executive Officer, Director Chembio Diagnostics Inc March 13, 2014 - May 30, 2017
John Sperzel's trades of T2 Biosystems Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
416.64
Quantity 99,683 -22.9%
Value US$233,434
Transaction date
Planned sale
Price
80.71
Quantity 48,169 +16.8%
Value US$2,194,657
Transaction date
Purchase
Price
355.81
Quantity 98,335 +12.0%
Value US$3,264,302
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-09 2023-02-28
PlS Planned sale
99,683 -22.9%
416.64
US$233,434 		99,683 -22.9% 416.64 US$233,434
2023-03-09 2023-02-22
PlS Planned sale
48,169 +16.8%
80.71
US$2,194,657 		48,169 +16.8% 80.71 US$2,194,657
2022-04-11 2022-04-07
B Purchase
98,335 +12.0%
355.81
US$3,264,302 		98,335 +12.0% 355.81 US$3,264,302